Articles related to COLORECTAL CANCER (CRC)

The “super enhancer,” a complex region of DNA with a lot of transcriptional machinery that determines whether a cell is malignant, can be programmed by the environment around a colon cancer tumor for the first time, according to research. The PDZK1IP1 gene, which was not previously recognized as a cancer gene, is controlled by this super enhancer, which is the biggest 1-2% of all enhancers in the cell. Colon cancer growth was inhibited when PDZK1IP1 was deleted, indicating that PDZK1IP1 and its super enhancer may be targets for cancer treatments.

According to reports, the second patient who passed away during the Phase 1 test of the cancer drug davoceticept by Alpine Immune Sciences experienced the same cardiovascular issue as the first patient.

In this randomized trial from Poland, Norway, Sweden, and the Netherlands, the study population of approximately 85,000 individuals were randomly assigned to colonoscopy screening or usual care. The risk of colorectal cancer at 10 years was 18% lower in the screening cohort.

The study, led by Michael Bretthauer, MD, PhD, of the University of Oslo in Norway, found that people who were invited to have a screening colonoscopy had a lower risk of colorectal cancer than those who were not, though at a lower rate than researchers expected. Furthermore, no significant difference in colorectal cancer-related mortality was discovered between the two groups.

This MashupMD link provides a video critique on YouTube of an NEJM paper on colonoscopy screening.

With just a few exceptions (p.I157T, p.S428F, and p.T476M), CHEK2 PVs were linked to comparable cancer phenotypes regardless of the variation type. Although CHEK2 PVs were linked to breast, kidney, and thyroid malignancies, they were not linked to colorectal cancer. The prevalent p.I157T, p.S428F, and p.T476M alleles have a weaker connection with breast cancer compared to other CHEK2 PVs and were not related with non-breast malignancies. These findings might help with genetic counseling and care for those with CHEK2 PVs.